• Fri, September 23, 2022

Geulah Livshits Initiated (SNTI) at Strong Buy and Held Target at $120 on, Sep 23rd, 2022

Geulah Livshits of Chardan Capital, Initiated "Senti Biosciences, Inc." (SNTI) at Strong Buy and Held Target at $120 on, Sep 23rd, 2022.

Geulah, nor any peers, have made any analyst calls on SNTI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍